The Science Behind the Vaccine featuring Dr. Dong Shen, RNAimmune
Interview with Q&A opportunities and optional networking featuring:
Dong Shen, M.D., Ph.D.
President and CEO, RNAimmune
Dong Shen, M.D., PhD., graduated from Johns Hopkins University School of Medicine, is the founder and CEO of RNAimmune. Headquartered in Gaithersburg, MD, RNAimmune’s messenger RNA proprietary technology is used to
develop cancer and antibody therapies and vaccines and the company is focused on developing a mRNA vaccine for COVID-19. Dr. Shen will discuss:
- Challenges in developing a successful vaccine for COVID-19 and the prospects for success
- Collaboration on vaccine development with government and commercial entities, locally, nationally and globally
- Strategies for implementing the worldwide distribution of effective vaccines
- Impact of the pandemic on the medical research community and opportunities it has created for company growth
Read recent press release.
Race for a Vaccine
Driving healthcare M&A and pharma deals
Investors lining up with funding
Companies reaping benefits with increased testing and related services
Strengthening important R&D and innovation
Speaker and Presenter Information
Dong Shen, M.D., Ph.D.
President and CEO, RNAimmune
Dong Shen, M.D., PhD., graduated from Johns Hopkins University School of Medicine, is the founder and CEO of RNAimmune. Headquartered in Gaithersburg, MD, RNAimmune’s messenger RNA proprietary technology is used to develop cancer and antibody therapies and vaccines and the company is focused on developing a mRNA vaccine for COVID-19.
Relevant Government Agencies
Dept of Health & Human Services, National Institutes of Health, State & Local Government
This event has no exhibitor/sponsor opportunities
When
Thu, Sep 24, 2020, 9:00am - 10:00am
ET
Cost
| Attendee: | $40.00 |
Website
Click here to visit event website
Organizer
ACG National Capital
